Trial Data Indicates Targeted, Short Course Radiation Therapy Preserves Urinary Continence and Sexual Function Better Than Surgery in Men With Prostate Cancer

SUNNYVALE, Calif., Feb. 16, 2023 -- (Healthcare Sales & Marketing Network) -- Accuray Incorporated (NASDAQ: ARAY) announced today that data from the randomized, multicenter trial PACE-A (PACE - Prostate Advances in Comparative Evidence) indicates that ste... Devices, Oncology Accuray, CyberKnife, stereotactic body radiation therapy
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news